openPR Logo
Press release

Fluoropolymer Films Market worth 2.62 Billion USD by 2022 | Key Players include The Chemours Company, Saint-Gobain, Nitto Denko, 3M, Daikin, Honeywell International, DUNMORE, Guarniflon, ACG Chemicals, and Textile Coated International

01-09-2019 12:40 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: MarketsandMarkets.com

Fluoropolymer Films Market, fep adhesive film, Fluoropolymer Films, fep films

Fluoropolymer Films Market, fep adhesive film, Fluoropolymer Films, fep films

According to recent research "Fluoropolymer Films Market by Type (PTFE, PVDF, FEP, PFA, ETFE Films), Application (Electrical & Electronics, Industrial, Automotive & Aerospace, Medical & Pharmaceutical, Consumer Products), and Region - Global Forecast to 2022", published by MarketsandMarkets™, The fluoropolymer films market is expected to grow from USD 1.97 Billion in 2017 and reach USD 2.62 Billion by 2022, at a CAGR of 5.9% between 2017 and 2022.

Browse 140 tables and 47 figures spread through 154 pages and in-depth TOC on "Fluoropolymer Films Market - Global Forecast to 2022"
https://www.marketsandmarkets.com/Market-Reports/flexible-epoxy-resin-market-192471059.html

Early buyers will receive 10% customization on this report.

The market is driven by the rising demand for fluoropolymer films from various applications, such as electrical & electronics, industrial, automotive & aerospace, and medical & pharmaceutical, for the manufacturing of semiconductors, electronic displays, wire & cables, release liners, laminates, and composite moldings.

The fluoropolymer films market size is projected to reach USD 2.62 billion by 2022, at a CAGR of 5.9% between 2017 and 2022. Films manufactured using several types of fluoropolymers, such as Polytetrafluoroethylene (PTFE), Polyvinylidene Fluoride (PVDF), Ethylene Tetrafluoroethylene (ETFE), Fluorinated Ethylene Propylene (FEP), and Perfluoroalkoxy Alkane (PFA) are called fluoropolymer films. These films are known for their significant physical properties, such as high-temperature tolerance, low coefficient of friction, chemical inertness, weather/UV resistance, and negligible moisture absorption. In addition, these films have superior dielectric properties across a wide range of temperature and frequency. High-performance properties of fluoropolymer films and increasing use of fluoropolymer films in medical & pharmaceutical applications are the major drivers of the global fluoropolymer films market during the forecast period.

Get FREE 10% Customization @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=208220440

Fluoropolymer film is a base material with significant physical properties, such as high-temperature tolerance, low coefficient of friction, chemical inertness, weather/UV resistance, and negligible moisture absorption. These films also have excellent optical and dielectric properties. Its unique capabilities make it preferable across applications, such as electrical & electronics, medical & pharmaceuticals, automotive & aerospace, and industrial. These films can be heat-sealed, metalized, laminated, thermoformed, welded, and die-stamped. These films have superior dielectric properties across a wide temperature and frequency range.

Expansions, acquisitions, new product developments, and partnerships were key strategies adopted by major players to achieve growth in the global fluoropolymer films market between 2015 and 2017. Major players in the fluoropolymer films market are The Chemours Company (US), Saint-Gobain (France), Nitto Denko (Japan), 3M (US), Daikin (Japan), Honeywell International (US), DUNMORE (US), Guarniflon (Italy), ACG Chemicals (Japan), and Textile Coated International (US).

For more Details Speak to Our Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=208220440

Daikin adopted expansions and acquisitions as its major strategies to increase its presence in the market and to cater the increasing demand for fluoropolymer films products. In August 2017, Daikin established a new subsidiary, DAIKIN CHEMICAL SOUTHEAST ASIA in Thailand to increase the sales of fluoropolymer and fluoroelastomer products to the automotive industry. With this expansion, the company aims to expand its fluorochemical business in the Southeast Asian market. In the same year, Daikin planned to acquire Heroflon (Italy), a manufacturer of high-performance fluoropolymer compounds and micro-powders focusing on PTFE. With this acquisition, the company expects to enter the compound business for fluoropolymers and utilize its global network to expand sales of Heroflon’s products.

The Chemours Company adopted expansions as its major strategy to strengthen its R&D capacities. In February 2017, The Chemours Company in partnership with the University of Delaware conducted a groundbreaking ceremony to build a new state-of-the-art research and innovation facility at the University of Delaware's Science, Technology and Advanced Research (STAR) Campus. The state-of-the-art facility will be named as The Chemours Discovery Hub. The company plans to invest USD 150 million for this expansion and expects to conduct research focused on new process, product, and application development at this facility.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, and strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
newsletter@marketsandmarkets.com

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, and strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
newsletter@marketsandmarkets.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Fluoropolymer Films Market worth 2.62 Billion USD by 2022 | Key Players include The Chemours Company, Saint-Gobain, Nitto Denko, 3M, Daikin, Honeywell International, DUNMORE, Guarniflon, ACG Chemicals, and Textile Coated International here

News-ID: 1482981 • Views:

More Releases from MarketsandMarkets.com

Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure.
Concrete Surface Retarders Market worth $89.4 million by 2023 : Major Players are Sika (Switzerland), BASF (Germany), MAPEI (Italy), GCP Applied Technologies (US), CEMEX (Mexico), W. R. Meadows (US)
Concrete Surface Retarders Market worth $89.4 million by 2023 : Major Players ar …
The report "Concrete Surface Retarders Market by Raw Material (Organic Agents and Inorganic Agents), Type (Water-based and Solvent-based), Application (Residential and Commercial), and Region (North America, Europe, Asia Pacific) - Global Forecast to 2023", The concrete surface retarders market is projected to grow from USD 72.7 million in 2018 to USD 89.4 million by 2023, at a CAGR of 4.2% between 2018 and 2023. Increase in urban population, demand for
Precast Concrete Market worth $174.1 billion by 2025 | Major Players are Lafarge …
The report "Precast Concrete Market by Element (Columns & Beams, Floors & Roofs, Girders, Walls & Barriers, Utility Vaults, Pipes, Paving Slabs), Construction Type, End-use Sector (Residential, Non-residential) - Global Forecast to 2025" The global precast concrete market size is projected to grow from USD 130.6 billion in 2020 to USD 174.1 billion by 2025, at a CAGR of 5.9% from 2020 to 2025. The market is projected to grow
Fire Stopping Materials Market worth $2.4 billion by 2026 : Major Players are Hi …
The report "Fire Stopping Materials Market by Type (Sealants, Mortar, Boards, Putty &Putty Pads, Cast-in Devices), by Application (Electrical, Mechanical, Plumbing), End-Use (Commercial, Industrial & Residential), and Region - Global Forecast to 2026" MarketsandMarkets: The fire stopping materials market is projected to reach USD 2.4 billion by 2026, at a CAGR of 11.6% from USD 1.4 billion in 2021. Fire stopping is a fire protection system for sealings of any

All 5 Releases


More Releases for MarketsandMarkets™

Biomaterials Market Worth $64.2 billion | MarketsandMarkets™
Biomaterials Market in terms of revenue was estimated to be worth $45.2 billion in 2024 and is poised to reach $64.2 billion by 2029, growing at a CAGR of 7.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. The biomaterials market is estimated to grow at a CAGR of 7.3% during the forecast period of 2024 to 2029. The important factors impacting market growth are the growing
Cell Expansion Market Worth $26.7 billion | MarketsandMarkets™
Cell Expansion Market in terms of revenue was estimated to be worth $14.3 billion in 2024 and is poised to reach $26.7 billion by 2029, growing at a CAGR of 13.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. Some factors contributing to the growth of the global market includes increasing R&D investments in cell based research, growing focus on personalized medicine, and increasing number of strategic
Apheresis Market Worth $3.9 billion | MarketsandMarkets™
Apheresis Market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at a CAGR of 8.8% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the apheresis market is driven by rise in demand for source plasma from biopharmaceutical companies, upsurging demand for blood components and favourable reimbursement for apheresis. The increasing
Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure.
Pipette Calibrators Market Worth $391 million | MarketsandMarkets™
Pipette Calibrators Market in terms of revenue was estimated to be worth $286 million in 2024 and is poised to reach $391 million by 2029, growing at a CAGR of 6.5% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by rise in genomics and proteomics research, growth in portable and handheld devices, and establishment of new research facilities by pharmaceutical
Mice Model Market Worth $2.2 billion | MarketsandMarkets™
Mice Model Market in terms of revenue was estimated to be worth $1.5 billion in 2024 and is poised to reach $2.2 billion by 2029, growing at a CAGR of 8.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The rise in chronic diseases, such as cancer, diabetes, and cardiovascular disorders, and growing need for reliable and predictive animal models to facilitate drug discovery and development are